Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer
- PMID: 31866242
- PMCID: PMC7103489
- DOI: 10.1053/j.gastro.2019.12.012
Cumulative Burden of Colorectal Cancer-Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer
Abstract
Background & aims: Early-onset colorectal cancer (CRC, in persons younger than 50 years old) is increasing in incidence; yet, in the absence of a family history of CRC, this population lacks harmonized recommendations for prevention. We aimed to determine whether a polygenic risk score (PRS) developed from 95 CRC-associated common genetic risk variants was associated with risk for early-onset CRC.
Methods: We studied risk for CRC associated with a weighted PRS in 12,197 participants younger than 50 years old vs 95,865 participants 50 years or older. PRS was calculated based on single nucleotide polymorphisms associated with CRC in a large-scale genome-wide association study as of January 2019. Participants were pooled from 3 large consortia that provided clinical and genotyping data: the Colon Cancer Family Registry, the Colorectal Transdisciplinary Study, and the Genetics and Epidemiology of Colorectal Cancer Consortium and were all of genetically defined European descent. Findings were replicated in an independent cohort of 72,573 participants.
Results: Overall associations with CRC per standard deviation of PRS were significant for early-onset cancer, and were stronger compared with late-onset cancer (P for interaction = .01); when we compared the highest PRS quartile with the lowest, risk increased 3.7-fold for early-onset CRC (95% CI 3.28-4.24) vs 2.9-fold for late-onset CRC (95% CI 2.80-3.04). This association was strongest for participants without a first-degree family history of CRC (P for interaction = 5.61 × 10-5). When we compared the highest with the lowest quartiles in this group, risk increased 4.3-fold for early-onset CRC (95% CI 3.61-5.01) vs 2.9-fold for late-onset CRC (95% CI 2.70-3.00). Sensitivity analyses were consistent with these findings.
Conclusions: In an analysis of associations with CRC per standard deviation of PRS, we found the cumulative burden of CRC-associated common genetic variants to associate with early-onset cancer, and to be more strongly associated with early-onset than late-onset cancer, particularly in the absence of CRC family history. Analyses of PRS, along with environmental and lifestyle risk factors, might identify younger individuals who would benefit from preventive measures.
Keywords: Colon Cancer; EOCRC; Penetrance; SNP.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.
Figures


Comment in
-
Negative Age-Dependence of the Polygenic Risk Score Gradient for Colorectal Cancer.Gastroenterology. 2021 May;160(6):2214-2215. doi: 10.1053/j.gastro.2020.09.064. Epub 2020 Dec 30. Gastroenterology. 2021. PMID: 33387520 No abstract available.
References
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin 2016;66:7–30. - PubMed
-
- Phillips KA, Liang SY, Ladabaum U, et al. Trends in colonoscopy for colorectal cancer screening. Med Care 2007;45:160–7. - PubMed
-
- Cress RD, Morris C, Ellison GL, et al. Secular changes in colorectal cancer incidence by subsite, stage at diagnosis, and race/ethnicity, 1992–2001. Cancer 2006;107:1142–52. - PubMed
-
- Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut 2019:gutjnl-2019–319511. - PubMed
-
- Yeo H, Betel D, Abelson JS, et al. Early-onset colorectal cancer is distinct from traditional colorectal cancer. Clin Colorectal Cancer 2017;16:293–299.e6. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 CA067941/CA/NCI NIH HHS/United States
- U01 HG004446/HG/NHGRI NIH HHS/United States
- P01 CA087969/CA/NCI NIH HHS/United States
- K05 CA154337/CA/NCI NIH HHS/United States
- P30 DK034987/DK/NIDDK NIH HHS/United States
- U01 CA164930/CA/NCI NIH HHS/United States
- R01 CA207371/CA/NCI NIH HHS/United States
- U01 CA074783/CA/NCI NIH HHS/United States
- P30 CA042014/CA/NCI NIH HHS/United States
- U01 CA067941/CA/NCI NIH HHS/United States
- R01 CA197350/CA/NCI NIH HHS/United States
- R01 CA076366/CA/NCI NIH HHS/United States
- R35 CA197735/CA/NCI NIH HHS/United States
- RC2 AG036607/AG/NIA NIH HHS/United States
- P30 ES010126/ES/NIEHS NIH HHS/United States
- T32 HS026120/HS/AHRQ HHS/United States
- U01 HG004438/HG/NHGRI NIH HHS/United States
- U01 CA074799/CA/NCI NIH HHS/United States
- U10 CA037429/CA/NCI NIH HHS/United States
- U01 CA182883/CA/NCI NIH HHS/United States
- MR/N003284/1/MRC_/Medical Research Council/United Kingdom
- P30 CA015704/CA/NCI NIH HHS/United States
- Z01 CP010200/ImNIH/Intramural NIH HHS/United States
- U24 CA074783/CA/NCI NIH HHS/United States
- R01 CA206279/CA/NCI NIH HHS/United States
- P01 CA055075/CA/NCI NIH HHS/United States
- N01 CN067009/CN/NCI NIH HHS/United States
- UG1 CA189974/CA/NCI NIH HHS/United States
- R01 CA151993/CA/NCI NIH HHS/United States
- P50 CA150964/CA/NCI NIH HHS/United States
- R01 CA048998/CA/NCI NIH HHS/United States
- UM1 CA182934/CA/NCI NIH HHS/United States
- R01 CA189184/CA/NCI NIH HHS/United States
- U01 CA167552/CA/NCI NIH HHS/United States
- G1000143/MRC_/Medical Research Council/United Kingdom
- U24 CA074794/CA/NCI NIH HHS/United States
- R01 CA066635/CA/NCI NIH HHS/United States
- U24 CA074806/CA/NCI NIH HHS/United States
- U01 CA206110/CA/NCI NIH HHS/United States
- N01 PC035137/CA/NCI NIH HHS/United States
- R01 CA137178/CA/NCI NIH HHS/United States
- U24 CA097735/CA/NCI NIH HHS/United States
- U01 CA074794/CA/NCI NIH HHS/United States
- P30 CA008748/CA/NCI NIH HHS/United States
- 19167/CRUK_/Cancer Research UK/United Kingdom
- U01 CA167551/CA/NCI NIH HHS/United States
- HHSN261201300012I/CA/NCI NIH HHS/United States
- P30 CA076292/CA/NCI NIH HHS/United States
- P30 CA014089/CA/NCI NIH HHS/United States
- K08 CA230162/CA/NCI NIH HHS/United States
- 14136/CRUK_/Cancer Research UK/United Kingdom
- R01 CA081488/CA/NCI NIH HHS/United States
- N01 PC035142/CA/NCI NIH HHS/United States
- G0401527/MRC_/Medical Research Council/United Kingdom
- R01 CA201407/CA/NCI NIH HHS/United States
- R01 CA063464/CA/NCI NIH HHS/United States
- P01 CA033619/CA/NCI NIH HHS/United States
- P20 CA233216/CA/NCI NIH HHS/United States
- UM1 CA186107/CA/NCI NIH HHS/United States
- R01 CA042182/CA/NCI NIH HHS/United States
- U01 CA063464/CA/NCI NIH HHS/United States
- R01 CA060987/CA/NCI NIH HHS/United States
- U01 CA097735/CA/NCI NIH HHS/United States
- T32 ES013678/ES/NIEHS NIH HHS/United States
- R01 CA136726/CA/NCI NIH HHS/United States
- P30 CA016058/CA/NCI NIH HHS/United States
- R03 CA215775/CA/NCI NIH HHS/United States
- UM1 CA167552/CA/NCI NIH HHS/United States
- P20 CA252728/CA/NCI NIH HHS/United States
- K07 CA188142/CA/NCI NIH HHS/United States
- U01 CA122839/CA/NCI NIH HHS/United States
- S10 OD020069/OD/NIH HHS/United States
- 10119/CRUK_/Cancer Research UK/United Kingdom
- N01 RC037004/RC/CCR NIH HHS/United States
- U24 CA074799/CA/NCI NIH HHS/United States
- P01 CA196569/CA/NCI NIH HHS/United States
- 25004/CRUK_/Cancer Research UK/United Kingdom
- N01 CN045165/CN/NCI NIH HHS/United States
- U01 CA074806/CA/NCI NIH HHS/United States
- U24 CA074800/CA/NCI NIH HHS/United States
- P50 CA127003/CA/NCI NIH HHS/United States
- 10589/CRUK_/Cancer Research UK/United Kingdom
- UM1 CA182883/CA/NCI NIH HHS/United States
- K07 CA190673/CA/NCI NIH HHS/United States
- P30 CA071789/CA/NCI NIH HHS/United States
- 001/WHO_/World Health Organization/International
- MR/L01629X/1/MRC_/Medical Research Council/United Kingdom
- R37 CA054281/CA/NCI NIH HHS/United States
- U01 CA074800/CA/NCI NIH HHS/United States
- 10124/CRUK_/Cancer Research UK/United Kingdom
- 16561/CRUK_/Cancer Research UK/United Kingdom
- U19 CA148107/CA/NCI NIH HHS/United States